Jeil Pharm (002620) — Free Cash Flow Generation Index
Jeil Pharm (002620) has a Free Cash Flow Generation Index of -2.85x as of March 2026. Free cash flow of ₩-1.27 Billion represents -3% of operating cash flow (₩447.08 Million). Read Jeil Pharm (002620) total liabilities for a breakdown of total debt and financial obligations.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Jeil Pharm Free Cash Flow Generation Index (2011–2025)
Historical FCF Generation Index trend for Jeil Pharm across 8 annual periods. Explore Jeil Pharm (002620) reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.
Annual Free Cash Flow Generation for Jeil Pharm (2011–2025)
Year-by-year Free Cash Flow Generation Index for Jeil Pharm. For the full company profile including market capitalisation, see Jeil Pharm (002620) total market value.
| Year | FCG Index | Free Cash Flow (KRW) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2025 | -22.90x | ₩-8.94 Billion | ₩390.26 Million | ₩9.33 Billion | ▼ -4382.3% |
| 2024 | -0.51x | ₩-2.32 Billion | ₩4.54 Billion | ₩6.86 Billion | ▲ +33.7% |
| 2021 | -0.77x | ₩-10.33 Billion | ₩13.40 Billion | ₩23.69 Billion | ▼ -182.5% |
| 2019 | 0.93x | ₩23.56 Billion | ₩25.22 Billion | ₩37.69 Billion | ▲ +87.5% |
| 2017 | 0.50x | ₩2.95 Billion | ₩5.92 Billion | ₩2.94 Billion | ▼ -86.4% |
| 2016 | 3.67x | ₩41.68 Billion | ₩11.36 Billion | ₩30.33 Billion | ▲ +6.2% |
| 2015 | 3.46x | ₩9.48 Billion | ₩2.74 Billion | ₩6.74 Billion | ▲ +77.5% |
| 2011 | 1.95x | ₩46.03 Billion | ₩23.63 Billion | ₩22.40 Billion | — |